The Ryan White Center for Pediatric Infectious Diseases and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA
Indiana University Center for Global Health Equity, Indianapolis, Indiana, USA.
BMJ Open. 2024 Jan 9;14(1):e079138. doi: 10.1136/bmjopen-2023-079138.
Tuberculosis (TB) is a leading infectious cause of death globally. It is the most common opportunistic infection in people living with HIV, and the most common cause of their morbidity and mortality. Following TB treatment, surviving individuals may be at risk for post-TB lung disease. The TB Sentinel Research Network (TB-SRN) provides a platform for coordinated observational TB research within the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.
This prospective, observational cohort study will assess treatment and post-treatment outcomes of pulmonary TB (microbiologically confirmed or clinically diagnosed) among 2600 people aged ≥15 years, with and without HIV coinfection, consecutively enrolled at 16 sites in 11 countries, across 6 of IeDEA's global regions. Data regarding clinical and sociodemographic factors, mental health, health-related quality of life, pulmonary function, and laboratory and radiographic findings will be collected using standardised questionnaires and data collection tools, beginning from the initiation of TB treatment and through 12 months after the end of treatment. Data will be aggregated for proposed analyses.
Ethics approval was obtained at all implementing study sites, including the Vanderbilt University Medical Center Human Research Protections Programme. Participants will provide informed consent; for minors, this includes both adolescent assent and the consent of their parent or primary caregiver. Protections for vulnerable groups are included, in alignment with local standards and considerations at sites. Procedures for requesting use and analysis of TB-SRN data are publicly available. Findings from TB-SRN analyses will be shared with national TB programmes to inform TB programming and policy, and disseminated at regional and global conferences and other venues.
结核病(TB)是全球主要的传染病死因。它是 HIV 感染者中最常见的机会性感染,也是导致其发病率和死亡率的主要原因。在结核病治疗后,幸存的个体可能有罹患结核病后肺部疾病的风险。结核病监测研究网络(TB-SRN)为国际艾滋病流行病学数据库评估(IeDEA)联盟内协调观察性结核病研究提供了一个平台。
本前瞻性观察性队列研究将评估 11 个国家 16 个地点的 2600 名年龄≥15 岁的患者的结核病(经微生物学证实或临床诊断)治疗和治疗后结局,包括 HIV 合并感染和不合并感染患者。将使用标准问卷和数据收集工具从开始结核病治疗开始收集临床和社会人口统计学因素、心理健康、健康相关生活质量、肺功能以及实验室和影像学发现的数据,并在治疗结束后 12 个月进行随访。将对数据进行汇总,以进行拟议分析。
所有实施研究的地点均获得了伦理批准,包括范德比尔特大学医学中心人类研究保护计划。参与者将提供知情同意;对于未成年人,这包括青少年同意和其父母或主要照顾者的同意。按照当地标准和各地点的考虑因素,纳入了对弱势群体的保护措施。请求使用和分析 TB-SRN 数据的程序是公开的。TB-SRN 分析的结果将与国家结核病规划分享,以告知结核病规划和政策,并在区域和全球会议及其他场所传播。